To discover and develop new drugs and treatments

To improve the safety and efficacy of existing drugs

To reduce the cost of drug production

To increase the profits of pharmaceutical companies

Discovery, preclinical testing, clinical trials, regulatory approval, and marketing

Discovery, clinical trials, regulatory approval, and marketing

Discovery, preclinical testing, clinical trials, and marketing

Discovery, preclinical testing, regulatory approval, and marketing

To identify new drug targets

To develop new drug molecules

To test the safety and efficacy of new drugs in animals

To obtain regulatory approval for new drugs

To test the safety and efficacy of new drugs in animals

To develop new drug molecules

To identify new drug targets

To obtain regulatory approval for new drugs

Phase I, Phase II, Phase III, and Phase IV

Phase I, Phase II, and Phase III

Phase I and Phase II

Phase I

To test the safety of a new drug in a small group of healthy volunteers

To test the efficacy of a new drug in a large group of patients

To compare the safety and efficacy of a new drug to an existing drug

To obtain regulatory approval for a new drug

To test the efficacy of a new drug in a large group of patients

To test the safety of a new drug in a small group of healthy volunteers

To compare the safety and efficacy of a new drug to an existing drug

To obtain regulatory approval for a new drug

To compare the safety and efficacy of a new drug to an existing drug

To test the safety of a new drug in a small group of healthy volunteers

To test the efficacy of a new drug in a large group of patients

To obtain regulatory approval for a new drug

To obtain regulatory approval for a new drug

To test the safety of a new drug in a small group of healthy volunteers

To test the efficacy of a new drug in a large group of patients

To monitor the safety and efficacy of a new drug after it has been approved for marketing

To review and approve new drugs for marketing

To conduct clinical trials

To develop new drugs

To manufacture drugs

To promote new drugs to healthcare professionals and patients

To conduct clinical trials

To develop new drugs

To manufacture drugs

High cost, long development times, and regulatory hurdles

Lack of funding

Lack of qualified personnel

All of the above

Increased focus on personalized medicine and targeted therapies

Use of artificial intelligence and machine learning

Development of new drug delivery systems

All of the above

Development of new drugs and treatments for a wide range of diseases

Improved safety and efficacy of drugs

Reduced cost of drug development

All of the above